Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/cam4.3692 http://scihub22266oqcxt.onion/10.1002/cam4.3692 33381923!7897967!33381923     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Cancer+Med 2021 ; 10 (3): 1043-1056 Nephropedia Template TP {{tp|p=33381923|t=2021. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis |pdf=|usr=}}{{33381923}} gab.com Text The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis JO: Cancer Med http://www.kidney.de/pget.php?&tw=1&pmid=33381923 #FOAvip BACKGROUND: The relationship between cancer and COVID-19 has been revealed during the pandemic. Some anticancer treatments have been reported to have negative influences on COVID-19-infected patients while other studies did not support this hypothesis. METHODS: A literature search was conducted in WOS, PubMed, Embase, Cochrane Library, CNKI and VIP between Dec 1, 2019 and Sept 23, 2020 for studies on anticancer treatments in patients with COVID-19. Cohort studies involving over 20 patients with cancer were included. The characteristics of the patients and studies, treatment types, mortality, and other additional outcomes were extracted and pooled for synthesis. RRs and forest plots were adopted to present the results. The literature quality and publication bias were assessed using NOS and Egger's test, respectively. RESULTS: We analyzed the data from 29 studies, with 5121 cancer patients with COVID-19 meeting the inclusion criteria. There were no significant differences in mortality between patients receiving anticancer treatment and those not (RR 1.17, 95%CI: 0.96-1.43, I(2) =66%, p = 0.12). Importantly, in patients with hematological malignancies, chemotherapy could markedly increase the mortality (RR 2.68, 95% CI: 1.90-3.78, I(2) =0%, p < 0.00001). In patients with solid tumors, no significant differences in mortality were observed (RR 1.16, 95% CI: 0.57-2.36, I(2) =72%, p = 0.67). In addition, our analysis revealed that anticancer therapies had no effects on the ICU admission rate (RR 0.87, 95% CI: 0.70-1.09, I(2) =25%, p = 0.23), the severe rate (RR 1.04, 95% CI: 0.95-1.13, I(2) =31%, p = 0.42), or respiratory support rate (RR 0.92, 95% CI: 0.70-1.21, I(2) =32%, p = 0.55) in COVID-19-infected patients with cancer. Notably, patients receiving surgery had a higher rate of respiratory support than those without any antitumor treatment (RR 1.87, 95%CI: 1.02-3.46, I(2) =0%, p = 0.04). CONCLUSIONS: No significant difference was seen in any anticancer treatments in the solid tumor subgroup. Chemotherapy, however, will lead to higher mortality in patients with hematological malignancies. Multicenter, prospective studies are needed to re-evaluate the results. Twit Text FOAVip The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis ????Cancer Med http://www.kidney.de/pget.php?&tw=1&pmid=33381923 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33381923 #FOAvip English Wikipedia <ref>{{Cite pmid|33381923}}</ref> The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis #MMPMID33381923 Liu H; Yang D; Chen X; Sun Z; Zou Y; Chen C; Sun S Cancer Med 2021[Feb]; 10 (3): 1043-1056 PMID33381923show ga BACKGROUND: The relationship between cancer and COVID-19 has been revealed during the pandemic. Some anticancer treatments have been reported to have negative influences on COVID-19-infected patients while other studies did not support this hypothesis. METHODS: A literature search was conducted in WOS, PubMed, Embase, Cochrane Library, CNKI and VIP between Dec 1, 2019 and Sept 23, 2020 for studies on anticancer treatments in patients with COVID-19. Cohort studies involving over 20 patients with cancer were included. The characteristics of the patients and studies, treatment types, mortality, and other additional outcomes were extracted and pooled for synthesis. RRs and forest plots were adopted to present the results. The literature quality and publication bias were assessed using NOS and Egger's test, respectively. RESULTS: We analyzed the data from 29 studies, with 5121 cancer patients with COVID-19 meeting the inclusion criteria. There were no significant differences in mortality between patients receiving anticancer treatment and those not (RR 1.17, 95%CI: 0.96-1.43, I(2) =66%, p = 0.12). Importantly, in patients with hematological malignancies, chemotherapy could markedly increase the mortality (RR 2.68, 95% CI: 1.90-3.78, I(2) =0%, p < 0.00001). In patients with solid tumors, no significant differences in mortality were observed (RR 1.16, 95% CI: 0.57-2.36, I(2) =72%, p = 0.67). In addition, our analysis revealed that anticancer therapies had no effects on the ICU admission rate (RR 0.87, 95% CI: 0.70-1.09, I(2) =25%, p = 0.23), the severe rate (RR 1.04, 95% CI: 0.95-1.13, I(2) =31%, p = 0.42), or respiratory support rate (RR 0.92, 95% CI: 0.70-1.21, I(2) =32%, p = 0.55) in COVID-19-infected patients with cancer. Notably, patients receiving surgery had a higher rate of respiratory support than those without any antitumor treatment (RR 1.87, 95%CI: 1.02-3.46, I(2) =0%, p = 0.04). CONCLUSIONS: No significant difference was seen in any anticancer treatments in the solid tumor subgroup. Chemotherapy, however, will lead to higher mortality in patients with hematological malignancies. Multicenter, prospective studies are needed to re-evaluate the results. |Antineoplastic Agents/*therapeutic use[MESH] |COVID-19/epidemiology/*prevention & control/virology[MESH] |Humans[MESH] |Medical Oncology/methods/*statistics & numerical data[MESH] |Neoplasms/diagnosis/*therapy[MESH] |Outcome Assessment, Health Care/methods/statistics & numerical data[MESH] |Pandemics[MESH] |Prognosis[MESH] |SARS-CoV-2/*isolation & purification/physiology[MESH]The effect of anticancer treatment on cancer patients with COVID-19: A(epmc).pdf DeepDyve Pubget Overpricing